| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/30/2011 | EP1196196B8 Conjugate for mediating cell, compartment or membrane-specific transport of active substances |
| 03/30/2011 | EP1053023B2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 03/30/2011 | CN1602351B Islet cells from human embryonic stem cells |
| 03/30/2011 | CN101999002A Methods of diagnosing and treating PARP-mediated diseases |
| 03/30/2011 | CN101993892A Eukaryotic expression vector for expressing shRNA (short hairpin Ribonucleic Acid) in manner of targeting in cancer cells |
| 03/30/2011 | CN101993877A Human miR-296-5p antisense nucleic acid and application thereof |
| 03/30/2011 | CN101993875A ShRNA of human CSAG1 genes and application |
| 03/30/2011 | CN101993874A ShRNA of human Cxorf41 gene and application thereof |
| 03/30/2011 | CN101993873A shRNA of human ZCCHC13 gene and application thereof |
| 03/30/2011 | CN101993872A shRNA of human MAGEA9 gene and application thereof |
| 03/30/2011 | CN101993871A shRNA of human DUSP21 gene and application thereof |
| 03/30/2011 | CN101993498A Adenovirus vector avian influenza recombinant vaccine |
| 03/30/2011 | CN101993478A Multi-epitope recombinant protein of epstein-barr (EB) virus latent membrane protein 2 and application thereof |
| 03/30/2011 | CN101991864A Leptospira interrogans DNA (Deoxyribose Nucleic Acid) vaccine as well as construction method and application thereof |
| 03/30/2011 | CN101991863A Double-target DNA vaccine and constructing method thereof |
| 03/30/2011 | CN101991862A Cyclodextrin-polyethyleneimine-mediated supramolecular delivery system and preparation method |
| 03/30/2011 | CN101991852A Application of miR-494 inhibitor in preparing preparation for resisting bone calcium loss and promoting bone formation |
| 03/30/2011 | CN101284134B Preparation method of carrier for gene transfer |
| 03/29/2011 | US7915401 Compounds for the modulation of beta-catenin expression |
| 03/29/2011 | US7915400 RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA) |
| 03/29/2011 | US7915393 Compositions and methods for WT1 specific immunotherapy |
| 03/29/2011 | US7915381 Immunomodulatory flagellin peptide having at least about 10 amino acids; immunotherapy treatment of cancer |
| 03/29/2011 | US7915231 Antisense modulation of C-reactive protein expression |
| 03/29/2011 | US7915230 Reagents for transfection of eukaryotic cells |
| 03/29/2011 | US7915036 Compositions comprising T cell receptors and methods of use thereof |
| 03/29/2011 | US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits |
| 03/29/2011 | US7914780 Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
| 03/29/2011 | US7914537 Devices and methods for the restoration of a spinal disc |
| 03/29/2011 | CA2617341C Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 03/29/2011 | CA2463521C Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 03/29/2011 | CA2323058C Methods for the diagnosis and treatment of lung cancer by detection of proto-oncogene overexpression |
| 03/29/2011 | CA2263798C G-coupled receptor showing selective affinity for atp |
| 03/29/2011 | CA2239151C Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 03/29/2011 | CA2207815C Modulators of the function of fas/apo1 receptors |
| 03/29/2011 | CA2174354C Compositions of melanoma differentiation associated gene-7 (mda-7) in cancer diagnosis and treatment |
| 03/24/2011 | WO2011035244A2 Tctex-1 regulatory sequence region as stem cell marker |
| 03/24/2011 | WO2011034947A2 Reagents and methods for modulating cone photoreceptor activity |
| 03/24/2011 | WO2010137021A3 Method of generating connective tissue |
| 03/24/2011 | WO2010128793A3 Fat soluble vitamin and a derivative thereof induced by novel cationic chitosan, a method of producing same and drug delivery system containing same |
| 03/24/2011 | WO2010111522A3 Mesenchymal stem cells producing inhibitory rna for disease modification |
| 03/24/2011 | WO2010058227A3 NOVEL USES OF VEGFxxxB |
| 03/24/2011 | WO2010017544A3 Long - acting dna dendrimers as vectors for the delivery of sirna |
| 03/24/2011 | US20110071212 P185neu-encoding dna and therapeutical uses thereof |
| 03/24/2011 | US20110071210 Methods and compositions for the treatment of cancer or other diseases |
| 03/24/2011 | US20110071073 Detection of mutations in a gene associated with resistance to viral infection, OAS1 |
| 03/24/2011 | US20110070651 Recombinant viral vector for gene transfer into lymphoid cells |
| 03/24/2011 | US20110070644 Monocyte-Derived Stem Cells (MDSC) and Methods of Use Thereof |
| 03/24/2011 | US20110070262 Viral Vectors and Their Use in Therapeutic Methods |
| 03/24/2011 | US20110070203 Mesendoderm and mesoderm cell populations |
| 03/24/2011 | US20110070164 Post release modification of viral envelopes |
| 03/24/2011 | US20110070162 Rna interference mediating small rna molecules |
| 03/23/2011 | EP2298927A2 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 03/23/2011 | EP2298926A1 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| 03/23/2011 | EP2298924A2 Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA |
| 03/23/2011 | EP2298900A1 Compositions and methods for treating intracellular diseases |
| 03/23/2011 | EP2298897A1 Regulation of oncogenes by microRNAs |
| 03/23/2011 | EP2298896A1 Methods of inhibiting tumor cell proliferation with FOXM1 siRNA |
| 03/23/2011 | EP2298892A2 Treatment of eye disorders characterized by an elevated intraocular pressure by siRNAs |
| 03/23/2011 | EP2298890A1 Chinese hamster apoptosis-related genes |
| 03/23/2011 | EP2298889A1 Chinese hamster apoptosis-related genes |
| 03/23/2011 | EP2298888A1 Chinese hamster apoptosis-related genes |
| 03/23/2011 | EP2298887A1 Chinese hamster apoptosis-related genes |
| 03/23/2011 | EP2298878A2 Compositions and methods for the diagnosis of cancer |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298799A1 A gene encoding a multidrug resistance human p-glyoprotein homologue on chromosome 7p15-21 and uses thereof |
| 03/23/2011 | EP2298796A2 Staphylococcus aureus proteins and nucleic acids |
| 03/23/2011 | EP2298360A2 Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 03/23/2011 | EP2298359A1 Nucleic acid capable of controlling degranulation of mast cell |
| 03/23/2011 | EP2298358A1 Methods for delivery of nucleic acids |
| 03/23/2011 | EP2298357A1 Compositions and methods for regulated protein expression in gut |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298334A2 Tweak receptor |
| 03/23/2011 | EP2298333A2 Tweak receptor |
| 03/23/2011 | EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 03/23/2011 | EP2297185A1 Parvoviral capsid with incorporated gly-ala repeat region |
| 03/23/2011 | EP2296683A2 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
| 03/23/2011 | EP2296630A2 Delivery of nucleic acid complexes from particles |
| 03/23/2011 | EP2296627A2 Micelles for intracellular delivery of therapeutic agents |
| 03/23/2011 | EP1691844B1 Methods and compositions for treatment of interferon-resistant tumors |
| 03/23/2011 | EP1469878B1 Fgfr agonists |
| 03/23/2011 | EP1320386B1 A novel cationic lipopolymer as biocompatible gene delivery agent |
| 03/23/2011 | EP1285004B1 method of producing synthetic peptides |
| 03/23/2011 | EP0792166B1 Internalisation of dna, using conjugates of poly-l-lysine and a peptide integrin receptor ligand |
| 03/23/2011 | CN1893981B Methods and compositions for treatment of interferon-resistant tumors |
| 03/23/2011 | CN101988071A Hepatitis c virus vaccine |
| 03/23/2011 | CN101988070A White spot syndrome virus VP292 polypeptide and application thereof |
| 03/23/2011 | CN101988057A Promoter and application thereof |
| 03/23/2011 | CN101987203A Method for preparing magnetic gene-loaded lipid ultrasonic microbubble contrast medium |
| 03/23/2011 | CN101987197A Method and reagent for inhibiting invasiveness of cancer cells |
| 03/23/2011 | CN101451145B Tuberculosis gene vaccine based on T cell epitope as well as preparation method and use thereof |
| 03/23/2011 | CN101392261B Modified highly pathogenic porcine reproductive and respiratory syndrome virus ORF5 gene and application |
| 03/23/2011 | CN101085357B Non-virus nano nucleic acid transferring composite for curing gristle defection by injecting in joint cavity and preparing method thereof |
| 03/22/2011 | US7910722 RNAi therapeutic for treatment of hepatitis C infection |
| 03/22/2011 | US7910721 Nucleic acid-enzyme complex |
| 03/22/2011 | US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 03/22/2011 | US7910704 Human p53 splice variant displaying differential transcriptional activity |
| 03/22/2011 | US7910692 Immunogenic peptides and methods of use |
| 03/22/2011 | US7910566 Prevention and treatment of acute renal failure and other kidney diseases by inhibition of p53 by siRNA |
| 03/22/2011 | US7910565 Prostate cancer vaccine |
| 03/22/2011 | US7910564 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant |